(Q34972634)

5 August 2017

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites (English)

1 reference

Spontaneous bacterial peritonitis

5 August 2017

0 references

1 reference

1

Jasmohan S Bajaj

1 reference

5 August 2017

Yelena Zadvornova

2

1 reference

5 August 2017

Douglas M Heuman

3

1 reference

5 August 2017

Muhammad Hafeezullah

4

1 reference

5 August 2017

Raymond G Hoffmann

5

1 reference

5 August 2017

Arun J Sanyal

6

1 reference

5 August 2017

Kia Saeian

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

31 March 2009

1 reference

The American Journal of Gastroenterology

5 August 2017

1 reference

5 August 2017

104

1 reference

5 August 2017

5

1 reference

5 August 2017

1130-1134

1 reference

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

5 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Overuse of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Use of acid-suppressing drugs and the risk of bacterial gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Prevalence of duodenal ulcer in cirrhotic males referred for liver transplantation. Does the etiology of cirrhosis make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.80

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.80

1 reference

5 August 2017

1 reference